SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma 2013
- 491 Downloads
Nasopharyngeal carcinoma cases are not frequently encountered in our environment. Local stages are treated with radiotherapy. For advanced local stages, the association of chemotherapy with radiotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum-based chemotherapy and patients may achieve a long survival time.
KeywordsNasopharyngeal carcinoma Lymphoepithelioma Keratinizing tumours Radiotherapy Intensity modulated therapy (IMRT) CDDP-5FU
Conflict of interest
The authors declare that they have no conflict of interest relating to the publication of this manuscript.
- 1.Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002 cancer incidence, mortality and prevalence worldwide IARC CancerBase N. 5, version 2.0. Lyon:IARC Press; 2004.Google Scholar
- 4.Classification TNM. En: American joint committee on cancer: AJCC cancer staging handbook. 7th ed. New York: Springer; 2010.Google Scholar
- 6.Thephamongkol K, Zhou J, Browman G, Wong RKW, Chan JCK, Zeng Y, et al. Chemo-radiotherapy versus radiotherapy alone for nasopharyngeal carcinoma: a meta-analysis of 78 randomized controlled trials from English and not-English databases (abstract). Proc Am Soc Clin Oncol. 2004;23:491a.Google Scholar
- 7.Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT et al. Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma. Cochrane Database Syst Rev. 2006;8(4):1–24.Google Scholar